Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India
- Hypertension is a serious global public health problem. It accounts for 10% of all deaths in India and is the leading noncommunicable disease.1 Recent studies have shown that the prevalence of hypertension is 25% in urban and 10% in rural people in India.2 It exerts a substantial public health burden on cardiovascular health status and health care systems in India.3 Antihypertensive treatment effectively reduces hypertension-related morbidity and mortality.1 The cost of medications has always been a barrier to effective treatment.
| Author: | Dnyanesh LimayeORCiDGND, M. Kale, N. Chitre, D. Deshapande, R. Desai, Vaidehi Limaye, Gerhard FortwengelORCiDGND |
|---|---|
| URN: | urn:nbn:de:bsz:960-opus4-9160 |
| DOI: | https://doi.org/10.1016/j.curtheres.2016.05.005 |
| Parent Title (English): | Current Therapeutic Research |
| Document Type: | Article |
| Language: | English |
| Release Date: | 2016/07/14 |
| Tag: | India; antihypertensive; cost-effectiveness; hypertension |
| Volume: | 78 |
| Issue: | Supplement |
| First Page: | S2 |
| Link to catalogue: | 1685452329 |
| Institutes: | Fakultät III - Medien, Information und Design |
| DDC classes: | 610 Medizin, Gesundheit |
| Licence (German): |  Creative Commons - CC BY-NC-ND - Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International |
